Xun Chen

Dr. Xun Chen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Biomedical Optics Express
Verified
Journal Article
Closed access
XYXuefang Yang
Xuefang Yang
YWYe Wang
Ye Wang
HZHejun Zhang
Hejun Zhang
HQHaoye Qin
Haoye Qin
SWSiyu Wang
Siyu Wang
PWPu Wang
Pu Wang
Current endoscopy techniques have difficulties to provide both high resolution and large imaging depth, which significantly hinders the early diagnosis of gastric cancer. Here, we developed a label-free, large-depth, three-dimensional (3D) chromatic reflectance confocal endomicroscopy. In order to solve the problem of insufficient imaging depth of traditional chromatic confocal microscopy, a customized miniature objective lens both with large chromatic focal shift and correction for spherical aberration was used to focus light of different wavelengths at different depths of the sample simultaneously, and a fiber bundle containing 50000 single-mode cores was used to collect the confocal reflectance signal. To acquire detailed information along the axial direction at a faster speed, a high-speed multi-pixel spectrometer was used to realize simultaneous detection of multi-depth signals. Specifically, we have built up a label-free fiber-optic 3D chromatic reflectance confocal endomicroscopy, with 2.3 µm lateral resolution, imaging depth of 570 µm in 3D phantom and 220 µm in tissue, and 1.5 Hz 3D volumetric frame rate. We have demonstrated that the fiber-optic 3D chromatic confocal endomicroscopy can be used to image human gastric tissues ex vivo, and provide important morphological information for diagnosis without labeling. These results show the great potential of the fiber-optic 3D chromatic confocal endomicroscopy for gastric cancer diagnosis.

27 May 2024 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
CLChang Liu
Chang Liu
JWJiejun Wang
Jiejun Wang
JSJianghao Shen
Jianghao Shen
XCXun Chen
Xun Chen
NJNan Ji
Nan Ji
SYShuhua Yue
Shuhua Yue
Molecular genetics is highly related with prognosis of high-grade glioma. Accordingly, the latest WHO guideline recommends that molecular subgroups of the genes, including IDH, 1p/19q, MGMT, TERT, EGFR, Chromosome 7/10, CDKN2A/B, need to be detected to better classify glioma and guide surgery and treatment. Unfortunately, there is no preoperative or intraoperative technology available for accurate and comprehensive molecular subgrouping of glioma. Here, we develop a deep learning-assisted fiber-optic Raman diagnostic platform for accurate and rapid molecular subgrouping of high-grade glioma. Specifically, a total of 2,354 fingerprint Raman spectra was obtained from 743 tissue sites (astrocytoma: 151; oligodendroglioma: 150; glioblastoma (GBM): 442) of 44 high-grade glioma patients. The convolutional neural networks (ResNet) model was then established and optimized for molecular subgrouping. The mean area under receiver operating characteristic curves (AUC) for identifying the molecular subgroups of high-grade glioma reached 0.904, with mean sensitivity of 83.3%, mean specificity of 85.0%, mean accuracy of 83.3%, and mean time expense of 10.6 s. The diagnosis performance using ResNet model was shown to be superior to PCA-SVM and UMAP models, suggesting that high dimensional information from Raman spectra would be helpful. In addition, for the molecular subgroups of GBM, the mean AUC reached 0.932, with mean sensitivity of 87.8%, mean specificity of 83.6%, and mean accuracy of 84.1%. Furthermore, according to saliency maps, the specific Raman features corresponding to tumor-associated biomolecules (e.g. nucleic acid, tyrosine, tryptophan, cholesteryl ester, fatty acid, and collagen) were found to contribute to the accurate molecular subgrouping. Collectively, this study opens up new opportunities for accurate and rapid molecular subgrouping of high-grade glioma, which would assist optimal surgical resection and instant post-operative decision-making.

26 September 2025 in Biomedical Optics Express
Verified
Journal Article
Closed access
XLXueying Li
Xueying Li
SSShilong Sun
Shilong Sun
YZYipeng Zhang
Yipeng Zhang
CLChang Liu
Chang Liu
YYYan Yan
Yan Yan
SYShuhua Yue
Shuhua Yue
Precise and timely intraoperative classification of vocal cord leukoplakia is vital for early staging and detection of laryngeal cancer. Current endoscopic imaging, such as narrow-band imaging (NBI) and white-light laryngoscopy (WLI), has the capability to evaluate the malignancy, but has low sensitivity (<70%) for grading the low-risk dysplasia. For the vocal fold lesions, optical coherence tomography (OCT), a non-invasive imaging technology, has been widely used to show the texture and pixel change of lesions caused by squamous epithelial cell hyperplasia and atypical hyperplasia. Here, a handheld OCT probe (OD = 3 mm, length = 25 cm) was designed and fabricated, and a swept-source OCT system was built for vocal lesion monitoring during the surgery. Home-built OCT probe has both a small OD and a long length for penetration depth imaging with good quality, which may enable the accurate and timely intraoperative localization detection of vocal cord tissues. The probe system has a 2D imaging speed of 100 frames per second, 7.96 µm lateral resolution, 16.24 µm axial resolution, and an imaging depth of 2.12 ± 0.43 mm in vocal fold tissues. We collected 378 OCT b-scan images (114 low risk, 175 high risk, 89 malignant) from 12 patients (4 low risk, five high risk, three malignant). A total of eight features of single B-scan images were extracted, including the mean pixel intensity (PI), median PI, minimum PI, and maximum PI; meanwhile, the mean attenuation coefficient (AC), median AC, minimum AC, and maximum AC of A-lines. The random forest (RF) model achieved the best overall accuracy (92.59%) and recall (93.25%) for low risk, high risk, and malignant classification, using 5-fold validation, with each patient's assessment completed within 10 minutes. Our OCT system was demonstrated to provide rapid and accurate pathological diagnosis of vocal cord leukoplakia intraoperatively. Our handheld OCT system facilitates identification of low-risk dysplasia with a sensitivity of up to 84.21% during the surgery, offering critical guidance on whether to opt for conservative or surgical treatment based on the lesion's severity.

20 June 2024 in ACS Omega
Verified
Journal Article
Open access
HJHao Jia
Hao Jia
XCXun Chen
Xun Chen
JSJianghao Shen
Jianghao Shen
RLRujia Liu
Rujia Liu
PHPeipei Hou
Peipei Hou
SYShuhua Yue
Shuhua Yue
The rupture of atherosclerotic plaques remains one of the leading causes of morbidity and mortality worldwide. The plaques have certain pathological characteristics including a fibrous cap, inflammation, and extensive lipid deposition in a lipid core. Various invasive and noninvasive imaging techniques can interrogate structural aspects of atheroma; however, the composition of the lipid core in coronary atherosclerosis and plaques cannot be accurately detected. Fiber-optic Raman spectroscopy has the capability of in vivo rapid and accurate biomarker detection as an emerging omics technology. Previous studies demonstrated that an intravascular Raman spectroscopic technique may assess and manage the therapeutic and medication strategies intraoperatively. The Raman spectral information identified plaque depositions consisting of lipids, triglycerides, and cholesterol esters as the major components by comparing normal region and early plaque formation region with histology. By focusing on the composition of plaques, we could identify the subgroups of plaques accurately and rapidly by Raman spectroscopy. Collectively, this fiber-optic Raman spectroscopy opens up new opportunities for coronary atherosclerosis and plaque detection, which would assist optimal surgical strategy and instant postoperative decision-making. In this paper, we will review the advancement of label-free fiber-optic Raman probe spectroscopy and its applications of coronary atherosclerosis and atherosclerotic plaque detection.

29 May 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
WZWanhui Zhou
Wanhui Zhou
DLDaoning Liu
Daoning Liu
TFTinghe Fang
Tinghe Fang
XCXun Chen
Xun Chen
HJHao Jia
Hao Jia
SYShuhua Yue
Shuhua Yue

9 July 2025 in Advanced Intelligent Discovery
Verified
Journal Article
Open access
JLJianlin Liu
Jianlin Liu
RLRujia Liu
Rujia Liu
XZXinyan Zhang
Xinyan Zhang
XCXun Chen
Xun Chen
SYShuhua Yue
Shuhua Yue
Coherent Raman scattering (CRS) microscopy has emerged as a powerful label‐free imaging technique, offering unparalleled insights into biochemical compositions and processes. Recent advancements in deep learning have further expanded its capabilities, addressing critical challenges in image quality, analysis, and clinical applicability. This review systematically explores the integration of deep learning with CRS microscopy, focusing on two areas: (1) The integration of deep learning has overcome physical limitations in CRS imaging, improving its fundamental performance including denoising to tackle low SNR, deconvolution to break the diffraction limits, and hyperspectral unmixing to enhance molecular specificity. (2) The application of deep learning strengthens downstream CRS image analysis, including subcellular localization, virtual staining, and automated disease diagnosis. In addition, we also critically discuss emerging challenges, including the challenges in acquiring annotated datasets, generalization and interpretability of models, and clinical integration of miniaturized CRS microscopy. By bridging technological gaps and improving analytical robustness, the synergy between deep learning and CRS microscopy holds transformative potential for biomedical research and clinical translation.